Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04204850
Title Cabozantinib to Treat of Recurrent Liver Cancer Post Transplant (CaboTx)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.